Your session is about to expire
← Back to Search
Transcranial Magnetic Stimulation
Deep TMS for Stimulant Use Disorder (SUDdTMS Trial)
N/A
Waitlist Available
Led By Jean-Philippe Miron, MD
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Being voluntary and competent to consent to treatment
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to three months after end of the treatment
Awards & highlights
SUDdTMS Trial Summary
This trialwill test a new treatment for people struggling with substance use disorder: a magnetic coil placed on the head.
Who is the study for?
This trial is for adults who have been diagnosed with moderate or severe Stimulant Use Disorder, are currently using stimulants, and want to quit. They must be able to understand French or English, consent to treatment, and follow the schedule. People with severe medical conditions, unstable medication use, significant sensory impairments, other metal implants in their body (except dental), pregnant or breastfeeding women, and those with certain psychiatric conditions cannot participate.Check my eligibility
What is being tested?
The study is testing the feasibility and safety of a technique called H7-Coil deep Transcranial Magnetic Stimulation (TMS) as a potential treatment for people struggling with Stimulant Use Disorder. Participants will undergo sessions where magnetic fields stimulate brain regions involved in addiction.See study design
What are the potential side effects?
Potential side effects of deep TMS may include discomfort at the stimulation site on the scalp, headache during or after treatment, lightheadedness, twitching of facial muscles during stimulation sessions and rare risk of seizure.
SUDdTMS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am willing and able to agree to treatment.
SUDdTMS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to three months after end of the treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to three months after end of the treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adverse Events reported
Feasibility-related endpoints - adherence to dTMS
Feasibility-related endpoints - retention rates
Secondary outcome measures
Percentage change on General Anxiety Disorder (GAD-7)
Percentage change on Patient Health Questionnaire (PHQ-9)
Percentage change on Stimulants Craving Questionnaire
+2 moreSUDdTMS Trial Design
1Treatment groups
Experimental Treatment
Group I: H7-Coil Deep TMS TreatmentExperimental Treatment1 Intervention
H7-Coil Deep TMS Treatment
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
H7-Coil Deep TMS for CUD
2022
N/A
~20
Find a Location
Who is running the clinical trial?
Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
370 Previous Clinical Trials
129,854 Total Patients Enrolled
Jean-Philippe Miron, MDPrincipal InvestigatorCentre hospitalier de l'Université de Montréal (CHUM)
1 Previous Clinical Trials
30 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have severe psychiatric conditions like schizophrenia or bipolar disorder.I do not have any severe or unstable illnesses like heart, kidney, liver, or neurological conditions.You want to stop taking drugs that stimulate your body.You have a serious addiction to drugs or alcohol (excluding nicotine).You have a medical device implanted in your body like a pacemaker or a device in your head that cannot be safely removed.You are pregnant or currently breastfeeding.I take more than 2 mg of lorazepam daily or any anticonvulsant.I am willing and able to agree to treatment.I can speak and read either French or English.My medication for cravings or mental health has been the same for the last 4 weeks.
Research Study Groups:
This trial has the following groups:- Group 1: H7-Coil Deep TMS Treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger